Insider Trading & Ownership - RA Capital Nexus Fund II L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for RA Capital Nexus Fund II L.P.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-09
Sale
2024-08-13
5:03 pm
AN2 Therapeutics Inc.ANTXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
3,525,094$1.08$3,807,102300,853
(Indirect)
View
2024-06-27
Purchase
2024-07-01
9:29 pm
Eliem Therapeutics Inc.ELYMRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
13,008,546$3.84$49,952,8175,417,638
(Indirect)
View
2024-04-02
Purchase
2024-04-04
4:15 pm
Boundless Bio Inc.BOLDRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
312,500$16$5,000,000295,844
(Indirect)
View
2024-03-25
Purchase
2024-03-27
7:37 pm
ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,401,299$9.4836$13,289,41010,860,977
(Indirect)
View
2024-03-21
Purchase
2024-03-25
8:48 pm
LENZ Therapeutics Inc.LENZRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
998,009$15.03$15,000,075792,288
(Indirect)
View
2024-02-09
Purchase
2024-02-13
4:33 pm
PepGen Inc.PEPGRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
2,557,593$10.64$27,212,79010,689,545
(Indirect)
View
2023-09-21
Purchase
2023-09-25
4:30 pm
ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
2,700,000$3.0309$8,183,5269,459,678
(Indirect)
View
2023-08-29
Purchase
2023-08-31
5:26 pm
ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
3,750,000$6.2$23,250,0006,759,678
(Indirect)
View
2023-08-18
Purchase
2023-08-22
5:01 pm
AN2 Therapeutics Inc.ANTXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
1,777,778$9$16,000,0025,551,295
(Indirect)
View
2023-07-21
Purchase
2023-07-25
4:30 pm
Acumen Pharmaceuticals Inc.ABOSRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
5,161,290$7.75$39,999,99814,932,063
(Indirect)
View
2023-07-19
Purchase
2023-07-21
4:31 pm
Janux Therapeutics Inc.JANXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
495,008$12.46$6,167,8009,668,878
(Indirect)
View
2023-03-28
Purchase
2023-03-30
5:03 pm
DICE Therapeutics Inc.DICERA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
509,145$29.07$14,798,6937,856,612
(Indirect)
View
2023-03-23
Purchase
2023-03-27
5:01 pm
DICE Therapeutics Inc.DICERA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
498,556$26.99$13,457,3727,347,467
(Indirect)
View
2022-11-17
Purchase
2022-11-21
4:31 pm
Acrivon Therapeutics Inc.ACRVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,389,500$12.5$42,368,750426,302
(Indirect)
View
2022-10-17
Purchase
2022-10-19
4:32 pm
DICE Therapeutics Inc.DICERA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,640,000$36.5$59,860,0006,848,911
(Indirect)
View
2022-08-03
Purchase
2022-08-05
4:06 pm
AN2 Therapeutics Inc.ANTXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
1,909$7.5067$14,3303,773,517
(Indirect)
View
2022-07-26
Purchase
2022-07-28
5:16 pm
AN2 Therapeutics Inc.ANTXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
23,219$7.7813$180,6753,771,608
(Indirect)
View
2022-06-21
Purchase
2022-06-23
4:31 pm
AN2 Therapeutics Inc.ANTXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
302$7.99$2,4133,748,389
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-27
Option Award
2024-07-01
9:29 pm
N/A
N/A
Eliem Therapeutics Inc.ELYMRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
5,259,872$05,417,638
(Indirect)
View
2024-06-26
Option Award
2024-06-28
6:14 pm
N/A
2034-06-25
Eliem Therapeutics Inc.ELYMRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,000$010,000
(Indirect)
View
2024-06-26
Option Award
2024-06-28
4:35 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,850$09,176,502
(Indirect)
View
2024-06-20
Option Award
2024-06-24
5:36 pm
N/A
2034-06-19
Acrivon Therapeutics Inc.ACRVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
20,275$020,275
(Indirect)
View
2024-06-20
Option Award
2024-06-24
5:13 pm
N/A
2034-06-19
ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
40,000$040,000
(Indirect)
View
2024-06-20
Option Award
2024-06-21
4:14 pm
N/A
2034-06-19
PepGen Inc.PEPGRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
13,000$013,000
(Indirect)
View
2024-06-10
Option Award
2024-06-10
5:26 pm
N/A
2034-06-09
Acumen Pharmaceuticals Inc.ABOSRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
25,000$025,000
(Indirect)
View
2024-05-24
Option Award
2024-05-24
7:56 pm
N/A
2034-05-23
Werewolf Therapeutics Inc.HOWLRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
17,500$017,500
(Indirect)
View
2024-04-11
Option Award
2024-04-15
4:15 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,530,000$8.58,340,508
(Indirect)
View
2024-04-02
Conversion
2024-04-04
4:15 pm
N/A
N/A
Boundless Bio Inc.BOLDRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
38,296,702$0295,844
(Indirect)
View

Ownership
2024-03-27
8:16 pm
N/A
N/A
Boundless Bio Inc.BOLDRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
0$01,868,131
(Indirect)
View
2024-03-21
Option Award
2024-03-25
8:48 pm
2024-03-21
2027-10-30
LENZ Therapeutics Inc.LENZRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,343,318$0792,288
(Indirect)
View
2024-02-19
Equity Swap
2024-02-20
8:07 pm
N/A
N/A
Icosavax Inc.ICVXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
5,969,108$00
(Indirect)
View
2024-02-19
Disposition
2024-02-20
8:07 pm
N/A
N/A
Icosavax Inc.ICVXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
39,278$00
(Indirect)
View
2023-08-09
Equity Swap
2023-08-09
5:00 pm
N/A
N/A
DICE Therapeutics Inc.DICERA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Former 10% owners and Director
Director
7,856,612$00
(Indirect)
View
2023-08-09
Disposition
2023-08-09
5:00 pm
N/A
2032-06-06
DICE Therapeutics Inc.DICERA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Former 10% owners and Director
Director
21,250$00
(Indirect)
View
2023-06-27
Option Award
2023-06-28
9:00 pm
N/A
2033-06-26
ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
40,000$040,000
(Indirect)
View
2023-06-14
Option Award
2023-06-16
5:15 pm
N/A
2033-06-13
Janux Therapeutics Inc.JANXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
12,500$012,500
(Indirect)
View
2023-06-06
Option Award
2023-06-13
4:21 pm
N/A
2033-06-05
Acumen Pharmaceuticals Inc.ABOSRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
25,000$025,000
(Indirect)
View
2023-05-18
Option Award
2023-05-22
5:22 pm
N/A
2033-05-17
Eliem Therapeutics Inc.ELYMRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,000$010,000
(Indirect)
View
2022-11-17
Conversion
2022-11-21
4:31 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
4,925,218$0426,302
(Indirect)
View
2022-11-14
Option Award
2022-11-16
7:33 pm
N/A
2032-11-13
Acrivon Therapeutics Inc.ACRVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
35,235$035,235
(Indirect)
View
2022-11-08
Option Award
2022-11-10
6:00 pm
N/A
N/A
ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
3,009,678$0902,904
(Indirect)
View

Ownership
2022-11-09
8:30 pm
N/A
N/A
Acrivon Therapeutics Inc.ACRVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
0$01,421,008
(Indirect)
View
2022-06-15
Option Award
2022-06-21
4:30 pm
N/A
2032-06-14
Acumen Pharmaceuticals Inc.ABOSRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
25,000$025,000
(Indirect)
View
Goto 0, 1, Next